Edgewell Personal Care price target lowered to $23 from $26 at RBC Capital

RBC Capital lowered the firm’s price target on Edgewell Personal Care (EPC) to $23 from $26 and keeps an Outperform rating on the shares. The company slightly beat on Q4 top-line, though profitability and FY26 guidance left some to be desired, the analyst tells investors in a research note. The Fem Care divestiture should make for a higher growth/margin company over the long-term, and the ongoing optimization efforts will leave Edgewell on better footing once the external environment becomes more supportive, but this is not anticipated to drive material improvement in the near-term, the firm added.